Recurrence: all 3,523 studies
Page 17 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Recurrence of Odontogenic KeratocystCompletedNCT06071806Not applicable
- Does the Mesh Have to be Fixed in Laparoscopic eTEP Repair of Bilateral Inguinal Hernia?CompletedNCT06070207Not applicable
- Does the Mesh Have to be Fixed in Laparoscopic eTEP Repair of Inguinal Hernia?CompletedNCT06070142Not applicable
- Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple MyelomaTerminatedNCT06068400Not applicable
- Hernia Belt in Laparoscopic Inguinal Hernia RepairCompletedNCT06061068Not applicable
- Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)Active, not recruitingNCT06054113Phase 2
- Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple MyelomaWithdrawnNCT06050512Phase 1/2
- A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Active, not recruitingNCT06035497Phase 1/2
- Individualized Treatments in Adults With Relapsed/Refractory CancersCompletedNCT06024603Not applicable
- Interobserver Variability DesmoplasiaCompletedNCT06020612
- A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung InfectionCompletedNCT06016088Phase 1/2
- Complications and Recurrences After Mohs Micrographic Surgery and Slow MohsActive, not recruitingNCT06014619
- 10-year Results of Open Inguinal Hernia RepairCompletedNCT06008535
- A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerActive, not recruitingNCT06007937Phase 1/2
- MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of RelapseCompletedNCT06000306
- Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional TherapyCompletedNCT05990920Phase 1
- Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal CancerActive, not recruitingNCT05990543Phase 1/2
- Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
- A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell LymphomaTerminatedNCT05972720Phase 2
- Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute LeukemiasCompletedNCT05969002
- R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell LymphomaWithdrawnNCT05966233Phase 2
- Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin LymphomasTerminatedNCT05965505Phase 1
- Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT05961839Phase 1
- TES of Chloroquine for Pv in the Philippines in 2016CompletedNCT05958797
- Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) PatientsStatus unknownNCT05951855Phase 2
- Evaluation and Timing in an ERAS-like Structured Rehabilitation Program After Lumbar Spine SurgeryCompletedNCT05937997Not applicable
- A Comparative Study of 3-point With 1-point Mesh Fixation in TAPP for Gilbert Type III Inguinal HerniaCompletedNCT05929378Not applicable
- Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL StudyCompletedNCT05927558
- The Effectiveness of 3 Orthodontic Fixed Retention Schemes on Post-treatment Stability and Gingival RecessionActive, not recruitingNCT05926934Not applicable
- Expanded Access Program for RevumenibNo longer availableNCT05918913
- mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WithdrawnNCT05918250Phase 1
- Relapse and Failure Rates Between CAD/CAM and Conventional Fixed RetainersCompletedNCT05915273Not applicable
- Post-operative Adjuvant Therapy w/wo GammaTile + Systemic TherapyWithdrawnNCT05900908Phase 4
- A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.TerminatedNCT05896163Phase 1/2
- A Biomarker Screening Protocol for Participants With Solid TumorsTerminatedNCT05891197
- Eight Units Extended Maxillary Fixed RetainerCompletedNCT05889884Not applicable
- A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular LymphomaActive, not recruitingNCT05888493Phase 3
- Corneal Toxicity in Patients Treated by Belantamab MafodotinCompletedNCT05887206
- Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)Active, not recruitingNCT05883462Early Phase 1
- A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)TerminatedNCT05879744Phase 1
- A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
- Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory PerformanceCompletedNCT05847933Not applicable
- Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05845632
- A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)CompletedNCT05829226Phase 1
- Re-irradiation for Pelvic Recurrences in Rectal Cancer PatientsCompletedNCT05816980Phase 2
- Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based TherapyTerminatedNCT05815160Phase 1
- GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin LymphomaStatus unknownNCT05797948Not applicable
- Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 2
- A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Active, not recruitingNCT05784441Phase 1
- Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System TumorsActive, not recruitingNCT05768880Phase 1
- Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple MyelomaApproved for marketingNCT05757973
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive, not recruitingNCT05753501Phase 1
- The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.Status unknownNCT05752357
- HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWithdrawnNCT05740449Phase 1/2
- Clinical-immunological Features of Anti-NMDAR EncephalitisStatus unknownNCT05738668
- A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 ExpressionActive, not recruitingNCT05736731Phase 1/2
- Drug-screening in AML at Relapse for Targeted TreatmentCompletedNCT05732688Not applicable
- HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer StudyCompletedNCT05720767Phase 1
- A Study of MS-553 in Patients With Relapsed or Refractory B-cell LymphomaTerminatedNCT05720052Phase 1/2
- The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder CancerStatus unknownNCT05704231Not applicable
- Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic LeukemiaCompletedNCT05676710Phase 1
- A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaActive, not recruitingNCT05675449Phase 1
- Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT05673967
- A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesCompletedNCT05665530Phase 1
- Laparoscopic Primary Diaphragm Versus Mesh Repair for Hiatus Hernia: a Long-Term Follow-UpStatus unknownNCT05662735Phase 4
- A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 AntibodyActive, not recruitingNCT05662397Phase 1/2
- Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma PatientsActive, not recruitingNCT05651178Early Phase 1
- Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell DiseasesWithdrawnNCT05647512Phase 1/2
- Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.TerminatedNCT05645744
- CAR-NK Targeted CD19 for r/r B-cell MalignanciesStatus unknownNCT05645601Phase 1
- A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)TerminatedNCT05641324Phase 1
- Artificial Intelligence and Hepatocellular CarcinomaActive, not recruitingNCT05637788
- Impact of Catheter Ablation on ABC Risk ScoresCompletedNCT05635864
- Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)Active, not recruitingNCT05634707Early Phase 1
- Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerTerminatedNCT05631574Phase 1
- ARISTOCRAT: Blinded Trial of Temozolomide +/- CannabinoidsActive, not recruitingNCT05629702Phase 2
- ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AMLWithdrawnNCT05622591Phase 1
- REfractorinesS to Ibrutinib BTKi and Systemic Targeted TherapyCompletedNCT05621148
- AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerTerminatedNCT05617755Phase 1
- T1 Squamous Cell Carcinomas of the LipActive, not recruitingNCT05610293
- HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPICompletedNCT05602597Phase 1
- Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)Status unknownNCT05599737Not applicable
- Vorasidenib Expanded Access ProgramApproved for marketingNCT05592743
- Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up StudyCompletedNCT05591703
- A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)Active, not recruitingNCT05578976Phase 3
- A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell LymphomaActive, not recruitingNCT05574114Phase 1
- A Study to Investigate LYL845 in Adults With Solid TumorsTerminatedNCT05573035Phase 1
- HMPL-523 Food Effect and Proton Pump Inhibitor StudyCompletedNCT05571787Phase 1
- Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic SyndromeCompletedNCT05564650Phase 1
- An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder CancerStatus unknownNCT05559177Early Phase 1
- Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLLStatus unknownNCT05557903Phase 1
- A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)Active, not recruitingNCT05552976Phase 3
- StayFine: Personalised Relapse Prevention of Anxiety and Mood Disorders in YouthsActive, not recruitingNCT05551468Not applicable
- LILRB4 STAR-T Cells in the Treatment of R/R AML/CMMLCompletedNCT05548088Phase 1
- PROMs and Patellar Tracking After MPFL Reconstruction With or Without Tibial Tuberosity TranspositionTerminatedNCT05547269
- A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid TumorsActive, not recruitingNCT05537740Phase 1
- Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS PatientsCompletedNCT05528354Phase 2
- A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell LymphomaStatus unknownNCT05527275Phase 1/2
- First in Human Study of IMGN151 in Recurrent Gynaecological CancersActive, not recruitingNCT05527184Phase 1
- Factors Affecting The Recurrence Of Acute Cholecystitis After Treatment With Percutaneous CholecystostomyCompletedNCT05525442